FDG-PET/CT Assessment of the Cerebral Protective Effects of Hydrogen in Rabbits with Cardiac Arrest

Article ID: e210322202459 Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Anatomical imaging methods and histological examinations have limited clinical value for early monitoring of brain function damage after cardiac arrest (CA) in vivo.

Objective: We aimed to assess the cerebral protective effects of hydrogen in rabbits with CA by using fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT).

Methods: Male rabbits were divided into the hydrogen-treated (n=6), control (n=6), and sham (n=3) groups. Maximum standardized uptake values (SUVmax) were measured by FDG-PET/CT at baseline and post-resuscitation. Blood Ubiquitin C-terminal hydrolase-L1 (UCH-L1) and neuron-specific enolase (NSE) were measured before and after the operation. After surgical euthanasia, brain tissues were extracted for Nissl staining.

Results: SUVmax values first decreased at 2 and 24 h after resuscitation before rising in the hydrogentreated and control groups. SUVmax values in the frontal, occipital, and left temporal lobes and in the whole brain were significantly different between the hydrogen and control groups at 2 and 24 h postresuscitation (P<0.05). The neurological deficit scores at 24 and 48 h were lower in the hydrogentreated group (P<0.05). At 24 h, the serum UCH-L1 and NSE levels were increased in the hydrogen and control groups (P<0.05), but not in the sham group. At 48 and 72 h post-CA, the plasma UCH-L1 and NSE levels in the hydrogen and control groups gradually decreased. Neuronal damage was smaller in the hydrogen group compared to the control group at 72 h.

Conclusion: FDG-PET/CT could be used to monitor early cerebral damage, indicating a novel method for evaluating the protective effects of hydrogen on the brain after CA.

Keywords: Cardiopulmonary resuscitation, hydrogen, brain protection, FDG-PET/CT, UCH-L1, NSE.

Graphical Abstract

[1]
Kumar A, Avishay DM, Jones CR, et al. Sudden cardiac death: Epidemiology, pathogenesis and management. Rev Cardiovasc Med 2021; 22(1): 147-58.
[http://dx.doi.org/10.31083/j.rcm.2021.01.207] [PMID: 33792256]
[2]
Jiménez-Pavón D, Artero EG, Lee DC, et al. Cardiorespiratory fitness and risk of sudden cardiac death in men and women in the United States: A prospective evaluation from the aerobics center longitudinal study. Mayo Clin Proc 2016; 91(7): 849-57.
[http://dx.doi.org/10.1016/j.mayocp.2016.04.025] [PMID: 27378037]
[3]
Kiguchi T, Okubo M, Nishiyama C, et al. Out-of-hospital cardiac arrest across the World: First report from the International Liaison Com-mittee on Resuscitation (ILCOR). Resuscitation 2020; 152: 39-49.
[http://dx.doi.org/10.1016/j.resuscitation.2020.02.044] [PMID: 32272235]
[4]
Chiu YD, Villar SS, Brand JW, et al. Logistic early warning scores to predict death, cardiac arrest or unplanned intensive care unit re-admission after cardiac surgery. Anaesthesia 2020; 75(2): 162-70.
[http://dx.doi.org/10.1111/anae.14755] [PMID: 31270799]
[5]
Devriese J, Beels L, Maes A, Van De Wiele C, Gheysens O, Pottel H. Review of clinically accessible methods to determine lean body mass for normalization of standardized uptake values. Q J Nucl Med Mol Imaging 2016; 60: 1-11.
[6]
Arena F, Bardini P, Blasi F, et al. Gadolinium presence, MRI hyperintensities, and glucose uptake in the hypoperfused rat brain after repeat-ed administrations of gadodiamide. Neuroradiology 2019; 61(2): 163-73.
[http://dx.doi.org/10.1007/s00234-018-2120-3] [PMID: 30377745]
[7]
Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: An evolving paradigm. Trends Mol Med 2007; 13(5): 183-91.
[http://dx.doi.org/10.1016/j.molmed.2007.03.003] [PMID: 17403616]
[8]
Bagnall RD, Weintraub RG, Ingles J, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med 2016; 374(25): 2441-52.
[http://dx.doi.org/10.1056/NEJMoa1510687] [PMID: 27332903]
[9]
McCluskey SP, Plisson C, Rabiner EA, Howes O. Advances in CNS PET: The state-of-the-art for new imaging targets for pathophysiology and drug development. Eur J Nucl Med Mol Imaging 2020; 47(2): 451-89.
[http://dx.doi.org/10.1007/s00259-019-04488-0] [PMID: 31541283]
[10]
Huang G, Zhou J, Zhan W, et al. The neuroprotective effects of intraperitoneal injection of hydrogen in rabbits with cardiac arrest. Resuscitation 2013; 84(5): 690-5.
[http://dx.doi.org/10.1016/j.resuscitation.2012.10.018] [PMID: 23108240]
[11]
Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13(6): 688-94.
[http://dx.doi.org/10.1038/nm1577] [PMID: 17486089]
[12]
Chahal CAA, Salloum MN, Alahdab F, et al. Systematic review of the genetics of sudden unexpected death in epilepsy: Potential overlap with sudden cardiac death and arrhythmia-related genes. J Am Heart Assoc 2020; 9(1): e012264.
[http://dx.doi.org/10.1161/JAHA.119.012264] [PMID: 31865891]
[13]
Chaker L, van den Berg ME, Niemeijer MN, et al. Thyroid function and sudden cardiac death: A prospective population-based cohort study. Circulation 2016; 134(10): 713-22.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.020789] [PMID: 27601558]
[14]
Dinc NS, Aydın K, Odabas H, et al. Pretreatment PET/CT standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer. Oncol Res Treat 2016; 39(3): 130-4.
[http://dx.doi.org/10.1159/000444272] [PMID: 27030981]
[15]
Kinahan PE, Fletcher JW. Positron emission tomography-computed tomography standardized uptake values in clinical practice and as-sessing response to therapy. Semin Ultrasound CT MR 2010; 31(6): 496-505.
[http://dx.doi.org/10.1053/j.sult.2010.10.001] [PMID: 21147377]
[16]
Nakajo M, Kajiya Y, Kaneko T, et al. FDG PET/CT and diffusion-weighted imaging for breast cancer: Prognostic value of maximum stand-ardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging 2010; 37(11): 2011-20.
[http://dx.doi.org/10.1007/s00259-010-1529-7] [PMID: 20607535]
[17]
Li YQ, Liao XX, Lu JH, et al. Assessing the early changes of cerebral glucose metabolism via dynamic (18)FDG-PET/CT during cardiac arrest. Metab Brain Dis 2015; 30(4): 969-77.
[http://dx.doi.org/10.1007/s11011-015-9658-0] [PMID: 25703241]
[18]
Bruikman C, de Ronde MWJ, Amin A, et al. Sudden cardiac death in families with premature cardiovascular disease. Heart 2020; 106(3): 228-32.
[PMID: 31422358]
[19]
Liu MC, Akinyi L, Scharf D, et al. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci 2010; 31(4): 722-32.
[http://dx.doi.org/10.1111/j.1460-9568.2010.07097.x] [PMID: 20384815]
[20]
Perkins GD, Ji C, Deakin CD, et al. PARAMEDIC2 Collaborators. A randomized trial of epinephrine in out-of-hospital cardiac arrest. N Engl J Med 2018; 379(8): 711-21.
[http://dx.doi.org/10.1056/NEJMoa1806842] [PMID: 30021076]
[21]
Skjelbred T, Lynge TH, Nielsen J, Winkel BG, Tfelt-Hansen J. Symptoms and healthcare contact preceding sudden cardiac death in persons aged 1-49 years. Trends Cardiovasc Med 2020.
[PMID: 31987774]
[22]
Tseng ZH, Olgin JE, Vittinghoff E, et al. Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD Study. Circulation 2018; 137(25): 2689-700.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.033427] [PMID: 29915095]
[23]
Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applica-tions: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging 2021; 48(1): 21-39.
[http://dx.doi.org/10.1007/s00259-020-04843-6] [PMID: 32430580]
[24]
Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 2010; 195(2): 310-20.
[http://dx.doi.org/10.2214/AJR.10.4923] [PMID: 20651185]